773 related articles for article (PubMed ID: 16858194)
1. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma.
Monchik JM; Donatini G; Iannuccilli J; Dupuy DE
Ann Surg; 2006 Aug; 244(2):296-304. PubMed ID: 16858194
[TBL] [Abstract][Full Text] [Related]
2. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
[TBL] [Abstract][Full Text] [Related]
3. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence.
Lanuti M; Sharma A; Willers H; Digumarthy SR; Mathisen DJ; Shepard JA
Ann Thorac Surg; 2012 Mar; 93(3):921-7; discussion 927-88. PubMed ID: 22296982
[TBL] [Abstract][Full Text] [Related]
5. Local progression after radiofrequency ablation for pulmonary metastases.
von Meyenfeldt EM; Prevoo W; Peyrot D; Lai A Fat N; Burgers SJ; Wouters MW; Klomp HM
Cancer; 2011 Aug; 117(16):3781-7. PubMed ID: 21319158
[TBL] [Abstract][Full Text] [Related]
6. Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation.
Park KW; Shin JH; Han BK; Ko EY; Chung JH
Ann Surg Oncol; 2011 Sep; 18(9):2564-8. PubMed ID: 21347777
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy.
Dupuy DE; Monchik JM; Decrea C; Pisharodi L
Surgery; 2001 Dec; 130(6):971-7. PubMed ID: 11742325
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
Yang W; Chen MH; Yin SS; Yan K; Gao W; Wang YB; Huo L; Zhang XP; Xing BC
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
[TBL] [Abstract][Full Text] [Related]
9. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
12. Simultaneous computed tomography-guided biopsy and radiofrequency ablation of solitary pulmonary malignancy in high-risk patients.
Schneider T; Puderbach M; Kunz J; Bischof A; Giesel FL; Dienemann H; Herth FJ; Schnabel PA; Safi S; Hoffmann H; Heussel CP
Respiration; 2012; 84(6):501-8. PubMed ID: 23037897
[TBL] [Abstract][Full Text] [Related]
13. [A case of recurrent esophageal cancer with lymph node and lung metastases, successfully treated with systemic chemotherapy and radiofrequency-ablation].
Ida S; Baba Y; Nagai Y; Iwagami S; Hayashi N; Watanabe M; Kawanaka K; Yamashita Y; Baba H
Gan To Kagaku Ryoho; 2012 Jan; 39(1):107-10. PubMed ID: 22241362
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation to treat loco-regional recurrence of well-differentiated thyroid carcinoma.
Lee SJ; Jung SL; Kim BS; Ahn KJ; Choi HS; Lim DJ; Kim MH; Bae JS; Kim MS; Jung CK; Chong SM
Korean J Radiol; 2014; 15(6):817-26. PubMed ID: 25469095
[TBL] [Abstract][Full Text] [Related]
15. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
16. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-Matched Cohort Study of 884 Patients.
Yan L; Zhang M; Song Q; Luo Y
Thyroid; 2021 Nov; 31(11):1662-1672. PubMed ID: 34269611
[No Abstract] [Full Text] [Related]
18. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
